The CEO and SAEO was extracted and obtained by Dr. Xu Ziheng’s group at Guangxi University of Chinese Medicine. The accuracy and reliability of the method were verified by Associate Professor Tao Junyu at the same institution. The primary reference methods (Haro-González et al., 2021; Ellboudy et al., 2023) for the extraction process are outlined as follows:

Cinnamon bark was crushed in a pulverizer (Model FW177, Tianjin, China) and sieved through a No. 4 sieve. Subsequently, 100 grams of the powdered cinnamon bark were mixed with 700 mL of water. The essential oil-water mixture was obtained via steam distillation. After 2 hours of heating, sodium chloride powder (supplied by Beijing Solarbio Science & Technology Co., Ltd., China) was added to the mixture to achieve a final concentration of 0.1 mg/mL. The mixture was then thoroughly mixed and poured into a separator for overnight static separation. The lower aqueous layer was discarded, while the yellowish upper layer was retained and placed in a sealed bottle containing anhydrous sodium sulfate (Beijing Solarbio Science & Technology Co., Ltd., China) for an overnight static period. Thereafter, the upper layer was transferred to a new bottle for light-avoiding storage at room temperature.

For the extraction of SAEO, the anise fruit was subjected to a crushing process using a No. 2 sieve. Subsequently, 50 grams of anise powder were combined with 500 mL of water and subjected to steam distillation for a period of 2 hours, during which time the essential oil and water mixture was formed. The subsequent processing steps were identical to those employed in the extraction of CEO.

Eight strains were obtained from the Guangxi University of Chinese Medicine in China. These strains were derived from Bellamya quadrata sold in various markets and identified as Salmonella Thompson by 16sRNA sequencing.

The strains were activated in the sterilized Luria-Bertani (LB) (Beijing Solarbio Science & Technology Co., Ltd., China) liquid medium through incubation on a constant temperature shaker (Shanghai Yuejin Medical Equipment Co., Ltd.) at 150 rpm and 37°C for 24 hours. And a crystal violet staining method (O'Toole and Kolter, 1998) was used to identify the strains with strong BF formation ability (Ommen et al., 2017).

The activated bacterial solution was inoculated into 96-well microtiter plates (Labgic Technology Co., Ltd., China) with a final concentration of 1×10⁶ CFU/mL and then incubated for 48 hours until the BF attained maturity. At first, most of the bacterial solution was decanted and washed twice with phosphate-buffered saline (PBS) (Labgic Technology Co., Ltd., China) to remove non-adherent cells. Subsequently, methanol (Chengdu Kelong Chemical Co., Ltd., China) was added for fixation for 15 minutes, after which the methanol was discarded and allowed to evaporate completely. Then, crystal violet staining was conducted for a period of five minutes, after which the crystal violet was discarded. After being washed with clear water until the effluent was colorless, anhydrous ethanol (Chengdu Kelong Chemical Co., Ltd., China) was added for decolorization. Finally, the absorbance was quantified at 570 nm with a microplate reader (Experiments were conducted using the INFINITE 200 PRO instrument made by Tecan Spark, Austria).

In brief, the mean optical density (OD) value of the negative control group was recorded as ODc (Atshan et al., 2012; Knobloch et al., 2002). BF formation ability was classified in the following ways: strong BF production (4 ODc < OD), moderate BF production (2ODc < OD ≤ 4ODc), weak BF production (ODc < OD ≤ 2ODc), and no BF production (OD ≤ ODc). The classification criteria were based on previous studies (Christensen et al., 1985; Stepanović et al., 2000) and were chosen to facilitate comparison with other BF formation bacteria.

In this study, the Salmonella C6304 exhibiting the highest OD values within the strong BF production group were selected for subsequent experiments.

A colony was selected from a freshly cultured bacterial plate and inoculated into LB broth for overnight incubation at 37°C. The bacterial suspension was then diluted with PBS to achieve a concentration of 1×10⁸ CFU/mL. Using a sterile cotton swab, the suspension was evenly spread onto MH agar plates. Sterile forceps were subsequently used to carefully place commercial antibiotic disks (Changde BKMAM Biotechnology Co., Ltd., China) containing predetermined concentrations of antimicrobial agents, onto the surface of the agar plates. Each plate received four distinct antibiotic disks, and this arrangement was replicated three times. The inoculated plates were then incubated at 37°C for 24 hours. After the incubation period, a vernier caliper was used to measure the diameters of the resulting inhibition zones. These measurements were analyzed in accordance with CLSI M100 (CLSI, 2021), which classify bacterial susceptibility to the respective antibiotics as sensitive (S), intermediate (I), or resistant (R). To ensure experimental accuracy, Escherichia coli (ATCC^® 25922™) and Staphylococcus aureus (ATCC^® 25923™) were used as quality control strains alongside the test strains in the antimicrobial sensitivity testing, validating the reliability of our experimental conditions and methodologies ( Supplementary Table S1 ).

In this study, we used a special MIC testing method to avoid interference from the inherent color of the essential oils and minimize human error in MIC determination. This method was mainly based on reference (Ksouda et al., 2019), with certain modifications made. The details of the modified MIC test method are as follows:

Tween-80 (Beijing Solarbio Science & Technology Co., Ltd., China) was incorporated into the MH broth medium at a dilution of 1%, as specified. A volume of 100 μL of CEO was added to a 10-mL dilution solution to achieve an initial concentration of 10 μL/mL. This mixture was then thoroughly homogenized. A total volume of 500 μL of the dilution solution was transferred to an EP tube (Beijing Labgic Technology Co., Ltd. China), and the master batch of CEO was serially diluted to concentrations of 10 μL/mL, 5 μL/mL, 2.5 μL/mL, 1.25 μL/mL, 0.62 μL/mL, 0.31 μL/mL, 0.16 μL/mL, and 0.08 μL/mL using the gradient dilution method. The dilution solution served as a blank. The SAEO was diluted using the same methodology described for the CEO, achieving final concentrations of 100 μL/mL, 50 μL/mL, 25 μL/mL, 12.5 μL/mL, 6.25 μL/mL, 3.12 μL/mL, 1.56 μL/mL, and 0.78 μL/mL.Additionally, the MIC of levofloxacin was tested at concentrations of 10 μg/mL, 5 μg/mL, 2.5 μg/mL, 1.25 μg/mL, 0.625 μg/mL, 0.312 μg/mL, 0.156 μg/mL, 0.078 μg/mL, 0.039 μg/mL.Escherichia coli (ATCC^® 25922™) and Staphylococcus aureus (ATCC^® 25923™) were used as quality control strains.

The test bacterial solution was diluted to 1×10⁷ CFU/mL, and then 50 μL was inoculated into EP tubes containing different drug concentrations. The tubes were incubated in a constant temperature shaking incubator at 37 ± 1°C at a speed of 150 rpm for 20 hours.

The detection protocol involved using a pipette gun to transfer 180 μL from each EP tube into 96-well plates, followed by the addition of 20 μL of a diluted 0.1% red tetrazolium salt solution (Beijing Solarbio Science & Technology Co., Ltd., China) to each well. The plates were then incubated for 4 hours. After this incubation period, the absorbance at 485 nm was measured by the microplate reader (INFINITE 200 PRO instrument made by Tecan Spark, Austria). Alternatively, the lowest concentration of drug solution at which the bacterial solution did not turn red was visually determined as the MIC.

To assess the combination effect of the two essential oils, a checkerboard method was employed. Specifically, 300 µL of each oil was pipetted into individual EP tubes in a systematic pattern.

Salmonella cultures were first incubated overnight and subsequently diluted 100-fold. Following this, 50 µL of the diluted culture was added to each EP tube containing the essential oil combinations. The tubes were then incubated for 20 hours at a constant temperature of 37°C in a shaking incubator set at 150 rpm.

After incubation, 180 µL from each EP tube was transferred to a 96-well plate. To each well, 20 µL of a 0.1% red tetrazolium saline solution (Beijing Solarbio Science & Technology Co., Ltd., China) was added. Following a four-hour incubation period, absorbance was measured at 485 nm using an enzyme marker (INFINITE 200 PRO, Tecan Spark, Austria). The MIC value was determined as the lowest concentration of the essential oil solution that did not result in a red coloration indicative of bacterial growth. Subsequently, the fractional inhibitory concentration (FIC) index was calculated (Xu et al., 2018; Requena et al., 2019).The FIC index is used to evaluate the effect of drug combinations. An FIC value less than or equal to 0.5 indicates synergism, a value greater than 0.5 but less than or equal to 4 indicates additivity, and a value greater than 4 indicates antagonism.

To prepare the broth dilutions, Tween 80 was added to sterilized MH broth at a concentration of 1%, followed by ultrasonic vortexing to ensure a homogeneous solution, crucial for proper dispersion during experiments. Subsequently, the CEO and SAEO were sequentially diluted to sub-MIC levels, with the initial concentration set as the starting point. Composite blends of these essential oils were also individually diluted to sub-synergistic concentrations (refer to results in 2.5). A gradient volume of 480 μL of the essential oil-containing solution was then added to Eppendorf tubes, followed by the addition of 20 μL of bacterial suspension to each tube, resulting in an initial bacterial concentration of approximately 1×10⁶ CFU/mL. The tubes were incubated at 37°C to evaluate the antibacterial activity. For comparison, a blank control (Tween-containing medium without essential oils) and a positive control (bacterial suspension without essential oils) were also included and incubated under the same conditions for various time points (1, 3, 6, 10, and 24 hours). Colony counts were performed at each time point to quantify bacterial viability, and a time-kill curve was constructed by plotting the mean colony count (log10 CFU/mL) against time, providing insight into the antibacterial efficacy of the essential oils over the course of the incubation.

To evaluate the antibacterial and anti-biofilm activities of the CEO and SAEO, broth dilutions were first prepared by adding Tween 80 to sterilized MH broth at a 1% concentration and then ultrasonically vortexing for homogeneity. The CEO and SAEO were sequentially diluted to sub-MIC levels, with the initial highest concentration serving as the starting point to assess their individual antibacterial activities at reduced concentrations. Additionally, composite essential oil blends were configured to sub-synergistic concentrations to evaluate their combined effects. A volume of 180 μL of the drug solution was dispensed in a gradient manner into each well of a 96-well plate, followed by the addition of bacterial solution to achieve an initial concentration of 1×10⁶ CFU/mL. Sterilized polypropylene screws were placed in each well and incubated at 37°C for 48 hours to assess bacterial adhesion and biofilm formation on a non-porous surface. After incubation, the screws were washed and stained with crystal violet to visualize adherent bacteria. The bound crystal violet was eluted with anhydrous ethanol, and the absorbance of the eluted solution was measured at 570 nm to quantify biofilm formation. This standardized method, similar to those employed in previous studies, enabled precise and reproducible quantification of bacterial biofilm on the screws, providing insights into the antibacterial and anti-biofilm properties of the tested essential oils.

This method allowed for the precise and reproducible quantification of bacterial BF formation on a standardized surface, providing valuable insights into the antibacterial and anti-BF activities of the tested essential oils. Similar methods have been used in previous studies to assess the efficacy of various antibacterial agents against BF-forming bacteria (Brożyna et al., 2022).

Drawing upon Junyu Tao’s work (Tao et al., 2021) with some methodological optimizations, the experimental procedures were as follows. For the preparation of broth dilution, Tween 80 was added to sterilized MH broth at a 1% ratio to facilitate the dispersion of the essential oils. In the preparation of the essential oil emulsion, two essential oils were sequentially diluted to sub-MIC levels, with the initial highest concentration as the starting point.

For the addition method, a volume of 1 mL of the drug solution was introduced into each EP tube according to a predetermined gradient. Subsequently, the bacterial solution was added to achieve an initial bacterial concentration of 1×10⁶ CFU/mL, ensuring consistent and precise dosing. After 9 hours of incubation, the bacterial suspension was centrifuged at 12000 rpm for 2 minutes (5424R, Eppendorf AG,German) to separate the bacterial cells from the broth. The supernatant was discarded, and the bacterial pellet was fixed in 2.5% formaldehyde electron microscope fixative at 4°C overnight.

The following day, the bacterial cells were washed with a series of ethanol solutions (40%, 60%, 80%, 90%, 95%, and 100%) to remove residual fixative and dehydrate the cells. After dehydration, the ethanol was replaced with ethyl acetate, and the bacterial cells were allowed to air-dry, resulting in a bacterial powder. This powder was then sprayed with gold (ISC 150 Ion Sputter Soater, supro instruments co. Ltd,China) to enhance conductivity and facilitate observation under an electron microscope (Phenom XL,Thermo Fisher Scientific, America).The observation conditions are set as follows: acceleration voltage of 5kv, beam current intensity in point mode, and probe mode in mixed mode.

Drawing inspiration from the methodological framework outlined (Tao et al., 2021), with subsequent optimizations, we devised the following experimental protocol. In a 6-well cell culture plate, 2 mL of drug solution (Same as in Step 2.8), containing essential oils diluted to sub-MIC or sub-synergistic concentrations was dispensed into each well according to a pre-established gradient. A calibrated volume of bacterial suspension was then inoculated into each well to achieve an initial bacterial concentration of 1×10⁶ CFU/mL. Round coverslips (25mm,biosharp therapeutics co. Ltd,China) were introduced as substrates for bacterial adherence and proliferation, and the plate was incubated under optimal conditions for 24 hours.

Upon completion of incubation, the round coverslips were gently extracted and subjected to a rigorous washing procedure, involving sequential immersion in ethanol solutions of increasing concentrations (40%, 60%, 80%, 90%, 95%, and 100%), with 10-minute intervals between each step, to eliminate residual culture media and fixatives. This was followed by two rinses with ethyl acetate and subsequent freeze-drying to preserve the intricate morphological features of the adherent bacteria. This round coverslips was then sprayed with gold (ISC 150 Ion Sputter Soater, supro instruments co. Ltd,China) to enhance conductivity and facilitate observation under an electron microscope (Phenom XL,Thermo Fisher Scientific, America).The observation conditions are set as follows: acceleration voltage of 5 kV, beam current intensity in point mode, and probe mode in mixed mode.

To quantitatively analyze the inhibition of bacterial adhesion following drug treatment, we employed ImageJ software (version 1.8.0_345) for processing the collected SEM images. In this study, we leveraged ImageJ’s automatic measurement to accurately calculate the area of bacterial clusters in 6 randomly selected fields of view at 1000× magnification for different drug treatment groups.

Log phase Salmonella cells (10⁸ CFU/mL) were added to 6-well microtiter plates after treatment with or without successive concentrations of CEO, SAEO and SCEO at 1/2 MIC concentration. The suspension was centrifuged at 5000 × g for 1 min and washed with DEPC-treated water. Cell lysates were collected and total RNA was isolated with TRIzol and then treated with DNAse. The cDNA template was reverse transcribed from the RNA using a Thermo Fisher Scientific Reverse Transcription Kit. The expression levels of target genes in Salmonella were determined by a fluorescence quantitative PCR (qPCR) assay as previously described. Expression values were calculated using the ΔΔCt method and expressed as fold change relative to control samples. gyrB was used as a housekeeping gene. All primers used in this study are listed in Table 1 .

The qPCR assay was performed with an initial denaturation step at 95°C for 3 minutes, followed by 40 cycles of amplification. Each amplification cycle consisted of denaturation at 95°C for 15 seconds, annealing at a temperature 55°C for 30 seconds, and extension at 72°C for 45 seconds. Following amplification, a melting curve analysis was conducted by gradually increasing the temperature from 60°C to 95°C, with fluorescence measurements taken at each 0.5°C increment to assess the specificity of the PCR products.

Salmonella was cultivated to the logarithmic growth phase. SAEO, CEO, SCEO and Levofloxacin—were subsequently diluted in MH broth to concentrations of MIC, 1/2MIC, and 1/4 MIC. To each EP tube containing 500 μL of diluted oil, 20 μL of Salmonella suspension was added, achieving a final concentration of 1 × 10⁸ CFU/mL. Following a 3-hour incubation at 37°C, the samples were centrifuged at 5000 rpm for 10 minutes, yielding supernatants.

For analysis, supernatants were processed per the alkaline phosphatase detection kit instructions (Beyotime Biotechnology, China). A blank control consisted of untreated but diluted Salmonella. Into a 96-well plate, 50 μL of supernatant was dispensed, followed by 50 μL of working solution. After 30 minutes, 100 μL of stop solution was added. Absorbance was measured at 425 nm, where darker reaction products indicated higher ALP activity. This procedure was triplicated for accuracy and reliability, with final results calculated as the average of measurements.

Salmonella was inoculated at a concentration of 1×10⁶ CFU/mL into a 6-well cell culture plate and incubated at 37°C for 24 hours. After removing the culture medium, SCEO was prepared in MH broth at concentrations of 1/4 MIC and 1/2 MIC and added to the wells for 3 hours, with blank MH broth as the control group. After 3 hours, the culture medium was removed, and the cells were washed twice with PBS. The FilmTracer™ Live/Dead Biofilm Viability Kit (Invitrogen, Thermo Fisher Scientific) was used to stain the cells, with PI (490/635 nm) and Syt9 (482/500 nm) added at working concentrations. The cells were incubated for 30 minutes, and fluorescence images were then captured using a Zeiss LSM 900 laser confocal microscope.

Data were analyzed using GraphPad Prism version 10.2 (GraphPad Software, Inc., La Jolla, CA, USA) for statistical calculations and graphical representations. Various statistical tests, including t-tests for pairwise comparisons and one-way analysis of variance (ANOVA) for multiple group comparisons, were performed as appropriate. The significance levels of P-values are denoted as follows: **** (P < 0.0001), *** (P < 0.001), ** (P < 0.01), and * (P < 0.05) indicate extremely highly significant, highly significant, significant, and somewhat significant differences, respectively. Conversely, a P-value greater than 0.05 (P > 0.05) suggests no significant difference.

For image assembly, Adobe Photoshop (Adobe Systems Incorporated, San Jose, CA, USA) was used to merge and adjust figure layouts without altering the integrity of the original data. Photoshop was strictly limited to non-quantitative adjustments, such as cropping, resizing, and minor color correction, to maintain consistency across all figures. Fluorescence microscopy images were processed using ZEN 3.8 (Carl Zeiss AG, Oberkochen, Germany) for image enhancement and analysis. The software facilitated adjustments to brightness, contrast, and other parameters to improve image clarity without affecting data interpretation. For scanning electron microscopy (SEM) image quantification, ImageJ (National Institutes of Health, Bethesda, MD, USA) was used.

To thoroughly evaluate its BF-forming ability, we employed the crystal violet staining method (The results after staining are shown in Supplementary Figure S3 ) for detection according to the data in Table 2 . The results indicate that all six bacterial strains tested exhibit robust BF-forming capabilities in Table 3 , the calculation result for Salmonella (C6304) is 2.56, which is significantly greater than 4 times the ODc value (ODc = 0.53). Therefore, it is identified as a strong BF-forming strain. Given its unique BF-forming characteristics, this strain has been selected as the core research subject for all subsequent experiments.

Based on Table 4 , the drug sensitivity test results indicate that Salmonella C6304 exhibits varying degrees of susceptibility to different classes of antibiotics. Specifically, the strain is sensitive to beta-lactam antibiotics such as ampicillin and cefazolin, as well as to aminoglycosides like amikacin and gentamicin. However, it demonstrates resistance to antibiotics within the same class, including oxacillin and piperacillin. Among fluoroquinolones, ciprofloxacin and norfloxacin show sensitivity, while levofloxacin falls into the intermediate category. Regarding macrolides, the strain is only sensitive to azithromycin and resistant to erythromycin. Additionally, imipenem, a carbapenem antibiotic, along with clindamycin and vancomycin from other classes, all exhibit resistance.

Based on Table 5 , the MIC of CEO is 0.625 μL/mL, while the MIC of SAEO is 25 μL/mL.As shown in Table 6 , the FIC of SAEO and CEO was 0.375, possessing synergistic bactericidal effect. The coordination ratio of SCEO was combined the 1/8 MIC (0.078 μL/mL) of CEO with 1/4 MIC (6.25 μL/mL) of SAEO, which as the MIC of SCEO.

Figure 1 explicitly demonstrates the variations in bacterial counts under different treatment conditions. Firstly, the bacterial count in the blank control group significantly increased within 24 hours, which intuitively reflects the natural proliferation rate of bacteria in the absence of drug intervention.

The drug-treated groups exhibited a pronounced bactericidal effect within the initial 6 hours, resulting in a rapid decline in bacterial counts. However, as time progressed, this bactericidal effect gradually diminished, and the rate of bacterial count reduction became more gradual. Despite this, the drug-treated groups were still able to control bacterial proliferation to a certain extent, ensuring that bacterial counts remained at a relatively low level for an extended period.

Notably, the 1/4 MIC SCEO drug group exhibited a relatively weak bactericidal effect in the initial stages, with a small reduction in bacterial counts. However, this does not imply that this drug group is completely ineffective. On the contrary, they were still able to inhibit bacterial growth to a certain extent, maintaining bacterial counts within a relatively stable range (approximately 10⁴ to 10⁶ CFU/mL) at 6 hours. This result indicates that although the CEO drug group exhibited a weaker bactericidal effect in the initial stages, its long-term effect may be limited, yet it still possesses a certain practical value.

In the Blank group ( Figure 2A ), the Salmonella cells exhibited a short and thick morphology, with a thick layer of membrane-like substances covering their surface, providing protection and stability. After treatment with SAEO ( Figure 2B ), the membrane-like substances on the cell surface almost completely disappeared, resulting in significantly enlarged voids, and the cell morphology transformed into a slender noodle-like shape. Compared to the normal group (Figure 2C), although the cells treated with CEO alone showed a tendency of rupture, the reduction in membrane-like substances was not as significant as that observed with SAEO alone. When SAEO was combined with CEO (Figure 2D), the membrane-like substances on the cell surface were greatly reduced, and the cells exhibited a distinct rupture morphology, with blurred boundaries between cells and adhesion to each other. This indicates that the active components in the SCEO have a synergistic destructive effect on both the surface and interior of the cells. Additionally, the significant reduction in the number of cells after treatment further confirms the remarkable inhibitory effect of these essential oils on Salmonella.

From Figure 3 , it is observed that there are significant differences in the inhibition rates of Salmonella BF formation by SAEO and CEO at different concentrations. Specifically, SAEO and CEO at 1/2 MIC both exhibited inhibition rates of approximately 45% and 75%, indicating that both treatments have a certain effect on inhibiting bacterial BF formation. However, when the concentration was reduced to 1/4 MIC, the inhibition rates generally decreased, with CEO approaching 30% and SAEO also showing a slight reduction. Notably, SCEO at 1/2 MIC (a combination essential oils of 1/8 MIC SAEO and 1/4 MIC CEO) exhibited a significant advantage in inhibition rate, reaching approximately 75%, demonstrating a stronger ability to inhibit bacterial BF formation compared to single-component essential oils. As the drug concentration decreases, the inhibition rate generally shows a downward trend, suggesting that drug concentration is a crucial factor affecting the inhibitory effect.

Observations of Salmonella in the adherent state were conducted using scanning electron microscopy, revealing that SAEO significantly reduced the aggregation behavior of Salmonella ( Figure 4D1 ). Compared to the blank group ( Figure 4A1 ), the number of bacterial colonies present in clusters was significantly decreased. CEO exhibited ( Figure 4C1 ) limited inhibitory capacity against this aggregation behavior, with some bacterial clumps still observable under the field of view. Notably, SCEO not only demonstrated an intervention effect on the aggregation behavior of Salmonella ( Figure 4E1 ) but also had a relatively pronounced disturbance on the bacterial cells. As depicted in Figures 4E2, A2 , the individual bacterial cells underwent significant shrinkage, suggesting that SCEO may exert an effect on the Salmonella cell membrane, thereby preventing the formation of BF. The Figure 5 reveals no notable discrepancy between the control and Tween groups, implying that the solvent has no impact on Salmonella aggregation. In contrast to the control, the CEO group displays a marked difference, indicating CEO’s ability to hinder Salmonella aggregation, albeit less effectively than SAEO, which performs notably better. Notably, when CEO is combined with SAEO, SCEO exhibits the most potent inhibition of Salmonella aggregation and adhesion at a reduced drug concentration.

Figure 6 provides a detailed illustration of the alterations in the expression of several key BF-related genes (bcsA, adrA, csgA, csgD) in Salmonella following drug treatment. From the figure, it can be seen that different drug treatment conditions significantly affected gene expression. The CEO treatment group showed no significant changes compared with the blank group, and the SAEO and SCEO treatments significantly up-regulated the expression of bcsA, adrA, csgA, and csgD genes. However, this does not imply that the formation of the biofilm was promoted.

Figure 7A demonstrates that at the MIC, both SCEO and SAEO alone can effectively induce the leakage of alkaline phosphatase, indicating their disruptive effects on bacterial cell walls. Notably, SCEO exhibits a more potent disruptive effect than SAEO alone, whereas the disruptive effects of CEO alone or levofloxacin at the same concentration are not evident within 3 hours. Figure 7B reveals that at half the MIC (1/2MIC), the disruptive effects of SCEO and SAEO on bacterial cell walls are comparable, with both showing similar efficacy. Figure 7C illustrates that when the concentration is reduced to one-quarter of the MIC (1/4MIC), the disruptive effect of SCEO is lower than that of SAEO used alone, highlighting the strong dependence of SCEO’s effect on its concentration. Conversely, SAEO retains some activity at this lower concentration. Figure 7D provides an overall view, showing that as the drug concentration decreases, the disruptive effects of both SAEO and SCEO on bacterial cell walls decline. However, the decline in SAEO’s effect is less pronounced than that of SCEO.

Collectively, at the MIC, SCEO exhibits a stronger effect than SAEO or CEO alone, further confirming the synergistic interaction between the components of SCEO (i.e., CEO and SAEO), which produces an effect greater than the sum of their individual effects when combined.

Figure 8 shows the damage to the bacterial cell membrane after treatment. When the bacterial cell membrane is damaged, PI can penetrate through the membrane’s compromised pores and enter the cell, emitting red fluorescence upon excitation. In contrast, when the cell membrane is intact, PI cannot enter the cell, while Syto 9 can pass through the membrane and emit green fluorescence. This allows for differentiation between live and dead bacteria. From Figures 8A1-C1 , it is evident that the green fluorescence in A1 covers a large area of the field of view. By comparing A2 and A3, we observe that the bacteria are intact at this stage. After 3 hours of treatment with SCEO at 1/4 MIC, B1 shows a noticeable reduction in green fluorescence spots, along with the appearance of red fluorescence spots, indicating that the bacterial cell membrane is damaged. In C1, after treatment with SCEO at 1/2 MIC, the green fluorescence spots further decrease, and the red fluorescence spots also decrease correspondingly. This might be due to the higher concentration of essential oil disrupting the bacterial integrity, leading to a general reduction in the number of viable cells. It is also worth noting that the green spherical particles in the field of view may represent residual essential oil components that were not completely washed away.